0001179110-19-007184.txt : 20190605 0001179110-19-007184.hdr.sgml : 20190605 20190605160639 ACCESSION NUMBER: 0001179110-19-007184 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190604 FILED AS OF DATE: 20190605 DATE AS OF CHANGE: 20190605 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KISHBAUCH MICHAEL D CENTRAL INDEX KEY: 0001076979 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37467 FILM NUMBER: 19879768 MAIL ADDRESS: STREET 1: 18 CHERRYVILLE RD CITY: FLEMINGTON STATE: NJ ZIP: 08822 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CATABASIS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001454789 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE KENDALL SQUARE STREET 2: BLDG. 1400E, SUITE B14202 CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-349-1971 MAIL ADDRESS: STREET 1: ONE KENDALL SQUARE STREET 2: BLDG. 1400E, SUITE B14202 CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 edgar.xml FORM 4 - X0306 4 2019-06-04 0 0001454789 CATABASIS PHARMACEUTICALS INC CATB 0001076979 KISHBAUCH MICHAEL D C/O CATABASIS PHARMACEUTICALS, INC. ONE KENDALL SQ, BLDG 1400E, STE B14202 CAMBRIDGE MA 02139 1 0 0 0 Stock Option (right to buy) 6.53 2019-06-04 4 A 0 7500 0 A 2029-06-03 Common Stock 7500 7500 D This option was granted on June 4, 2019 and is scheduled to vest in full on June 4, 2020. /s/ Deirdre A. Cunnane as attorney-in-fact for Michael D. Kishbauch 2019-06-05